Insider filing · ALNY
Pushkal Garg
EVP Chief R&D
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 56 filings in 24 months
ticker →
Pushkal Garg sold $1.4M of Alnylam Pharmaceuticals (ALNY)
Executed Feb 27, disclosed Mar 2, 3 days later.
Value, as filed
$1.4M
4,360 sh across 3 lots
Executed
Feb 27
the trade date, as filed
Disclosed
Mar 2
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PGPushkal Garg (EVP Chief R&D) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $2.3M of ALNY (5,170 sh across 10 lots, as filed), executed Oct 2 2025.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Pushkal Garg in ALNY
ALNYSALE
Alnylam Pharmaceuticals, Inc.
$1.1M3,521 sh across 6 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $821K
2,549 sh across 6 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $695K
2,242 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.3M
5,170 sh across 10 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $1.2M
2,523 sh across 8 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.9M
9,766 sh across 2 lots
Exec Mar 21 2025
Filed Mar 25 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $142K
583 sh × $243.13
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $216K
862 sh × $250.11
Exec Feb 18 2025
Filed Feb 18 2025 · 5:30 PM ET